SEC Filing: NovoCure Ltd (NVCR) Reports An executive or director departure

A Form 8-K filed by NovoCure Ltd (NVCR) with the SEC on 2026-09-09 discloses an executive or director departure.

Public companies are required to file a Form 8-K with the SEC within four business days of a material corporate event, covering matters ranging from leadership changes to major agreements and financial results.

Investors can review the full filing directly through the SEC's EDGAR database for additional detail beyond what is summarized here.